Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05147285
Other study ID # KA-20069
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date October 22, 2020
Est. completion date May 20, 2022

Study information

Verified date April 2024
Source Hacettepe University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of this study is to examine the effects of different exercise modalities applied with tele-rehabilitation on functional capacity, oxidative stress and respiratory parameters in children with cystic fibrosis


Description:

Cystic fibrosis (CF) is the most common life-shortening autosomal recessive disease among populations of caucasians with a frequency of 1 in 2000 to 3000 live births. The most common problems in these patients are increased bronchial secretion, decreased exercise capacity, and shortness of breath. In addition to progressive respiratory disease, peripheral and respiratory muscle function impairments, inflammation, and contribute to the decrease in exercise capacity in CF patients. Recent studies show that increased oxidative stress and impaired oxidant / antioxidant capacity have an important role in disease progression in CF patients. CF childrens may be more physically inactive. Cystic fibrosis transmembrane regulator (CFTR) modulators, airway clearance therapies, chest physiotherapy and exercise trainings are treatment options in these populations. Regular exercise which is the component of pulmonary rehabilitation (PR), is recommended for patients with CF. Aerobic exercise may help to mobilize secretions, in addition to providing the other known benefits of exercise in healthy individuals. Despite the benefits of PR programmes, low participant uptake, high drop-out rates, financial and transportation difficulties reduced the attendance in these programs. Different telemedicine treatments have been developed to overcome these difficulties and reduce healthcare costs. In recent studies, shows that tele-exercise is a promising new approach to promote exercise in children with CF. Although different exercise modalities such as aerobic exercise training and strength training have been investigated in CF patients, there is no study to examine stabilization exercises in this populations. Also there is no study to evaluate the effect of exercise training on irisin. In addition, although it is known that acute exercise has positive effects on both oxidant and antioxidant markers in the pediatric population, the effect of long-term exercise on oxidative stress has not been adequately studied. The aim of this study is to examine the effect of different exercise training modalities applied with telerehabilitation method on functional capacity, oxidative stress and respiratory parameters in CF patients. . In the study, after measuring respiratory functions, exercise capacity, oxidative stress parameters, peripheral muscle functions, balance, posture, quality of life and physical activity questionnaire, 39 people will be divided into three groups. First group will be applied only online supervised stabilization exercises, Second group will be applied online supervised aerobic exercise training and stabilization exercises. And the third group, the physical activity importance will be explained and appropriate physical activity recommendations will be made. All outcome measures will be repeated after exercise training.


Recruitment information / eligibility

Status Completed
Enrollment 39
Est. completion date May 20, 2022
Est. primary completion date May 20, 2022
Accepts healthy volunteers No
Gender All
Age group 8 Years to 18 Years
Eligibility Inclusion Criteria: - Patients aged 8-18 years with a diagnosis of cystic fibrosis (CF) - Access to online exercise training - Percent predicted of forced expiratory volume at one second (FEV1) > 40% in pulmonary function test Exclusion Criteria: - Being diagnosed with acute pulmonary exacerbation at the time of study and / or within the last month. - Being physically or perceptually competent to exercise - Patients with allergic bronchopulmonary aspergillosis (ABPA) who were treated with systemic steroid therapy - Having FEV1 %< 40% at pulmonary function test.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
stabilization exercises
Patients will be applied only online supervised stabilization exercises three times a week for 8 weeks.
combined exercises
Patients will be applied online supervised aerobic exercise training and stabilization exercises.Aerobic exercises will be performed for 8 weeks, for 30-45 minutes, at 65-75% of the maximum heart rate, 3 days a week, on the days when stabilization exercises are not performed.
Physical activity recommendations
The importance of physical activity will be explained to the patients and appropriate physical activity recommendations will be made.

Locations

Country Name City State
Turkey Hacettepe University Ankara

Sponsors (1)

Lead Sponsor Collaborator
Hacettepe University

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Primary six minute walk test distance Six-minute walk test distance is recorded before the exercise training
Primary six minute walk test distance Six-minute walk test distance is recorded eight week
Primary shuttle walk test distance shuttle walk test distance is recorded before exercise training
Primary shuttle walk test distance shuttle walk test distance is recorded eight week
Secondary Respiratory muscle strength Respiratory muscle strength will be evaluated using mouth pressure device before exercise training
Secondary Respiratory muscle strength Respiratory muscle strength will be evaluated using mouth pressure device eight week
Secondary Respiratory muscle endurance Respiratory muscle endurance will be evaluated using constant load test before exercise training
Secondary Respiratory muscle endurance Respiratory muscle endurance will be evaluated using constant load test eight week
Secondary Pulmonary functions-FVC Forced vital capacity (FVC) before exercise training
Secondary Pulmonary functions-FVC Forced vital capacity (FVC) eight week
Secondary Pulmonary functions-FEV1 Forced expiratory volume in the first second (FEV1) before exercise training
Secondary Pulmonary functions-FEV1 Forced expiratory volume in the first second (FEV1) eight week
Secondary Pulmonary functions-FEV1/FVC FEV1/ FVC before exercise training
Secondary Pulmonary functions-FEV1/FVC FEV1/ FVC eight week
Secondary Pulmonary functions-PEF Peak Expiratory Flow (PEF) before exercise training
Secondary Pulmonary functions-PEF Peak Expiratory Flow (PEF) eight week
Secondary Pulmonary functions-FEF25-75 Forced mid-expiratory flow (FEF25-75) before exercise training
Secondary Pulmonary functions-FEF25-75 Forced mid-expiratory flow (FEF25-75) eight week
Secondary Oxidative stress-MDA Malondialdehyde (MDA) will be determined in the blood samples. before exercise training
Secondary Oxidative stress-MDA Malondialdehyde (MDA) will be determined in the blood samples. eight week
Secondary Oxidative stress-SOD Superoxide dismutase (SOD) will be determined in the blood samples. before exercise training
Secondary Oxidative stress-SOD Superoxide dismutase (SOD) will be determined in the blood samples. eight week
Secondary Oxidative stress-CAT Catalase (CAT) will be determined in the blood samples. before exercise training
Secondary Oxidative stress-CAT Catalase (CAT) will be determined in the blood samples. eight week
Secondary Oxidative stress-PC Protein carbonyl (PC) will be determined in the blood samples. before exercise training
Secondary Oxidative stress-PC Protein carbonyl (PC) will be determined in the blood samples. eight week
Secondary Oxidative stress-TOS Total oxidant status (TOS) will be determined in the blood samples. before exercise training
Secondary Oxidative stress-TOS Total oxidant status (TOS) will be determined in the blood samples. eight week
Secondary Oxidative stress-TAS Total antioxidant status(TAS) will be determined in the blood samples. before exercise training
Secondary Oxidative stress-TAS Total antioxidant status (TAS) will be determined in the blood samples. eight week
Secondary Oxidative stress-oxidative stress index Oxidative stress index (TOS/TAS) before exercise training
Secondary Oxidative stress-oxidative stress index Oxidative stress index (TOS/TAS) eight week
Secondary Peripheral muscle strength Peripheral muscle strength will be evaluated using dynamometer before exercise training
Secondary Peripheral muscle strength Peripheral muscle strength will be evaluated using dynamometer eight week
Secondary crunch repetitions number of crunch completed is recorded before exercise training
Secondary crunch repetitions number of crunch completed is recorded eight week
Secondary squat repetitions number of squats completed is recorded before exercise training
Secondary squat repetitions number of squats completed is recorded eight week
Secondary push-up repetitions number of push-ups completed is recorded before exercise training
Secondary push-up repetitions number of push-ups completed is recorded eight week
Secondary plank duration duration of keeping plank position is recorded before exercise training
Secondary plank duration duration of keeping plank position is recorded eight week
Secondary 1 minute sit to stand test (STS) repetitions number of sit to stand for one minute is recorded before exercise training
Secondary 1 minute sit to stand test (STS) repetitions number of sit to stand for one minute is recorded eight week
Secondary myokine assessment irisin levels will be determined in the blood sample before exercise training
Secondary myokine assessment irisin levels will be determined in the blood sample eight week
Secondary posture-Corbin Posture will be evaluated using Corbin Postural Assessment scale. Lateral and posterior views will be assessed (0 = absent, 1 = mild, 2 = moderate, 3 = severe) and posture score will be determined as excellent (0-2), very good (3-4), good (5-7), fair (8-11) and poor (>12). before exercise training
Secondary posture-Corbin Posture will be evaluated using Corbin Postural Assessment scale. Lateral and posterior views will be assessed (0 = absent, 1 = mild, 2 = moderate, 3 = severe) and posture score will be determined as excellent (0-2), very good (3-4), good (5-7), fair (8-11) and poor (>12). eight week
Secondary posture Thoracic kyphosis and lumbar lordosis angles will be evaluated in the sagittal plane with spinal mouse device. before exercise training
Secondary posture Thoracic kyphosis and lumbar lordosis angles will be evaluated in the sagittal plane with spinal mouse device. eight week
Secondary balance Pediatric berg balance scale will be used. The scale consists of 14 parts. Each section is scored between 0-4. The highest score that can be obtained from the scale is 56.Higher score means a better outcome. before exercise training
Secondary balance Pediatric berg balance scale will be used. The scale consists of 14 parts. Each section is scored between 0-4. The highest score that can be obtained from the scale is 56.Higher score means a better outcome. eight week
Secondary static balance static balance will be evaluated functional reach test before exercise training
Secondary static balance static balance will be evaluated functional reach test eight week
Secondary dynamic balance Balance will be evaluated using one-legged standing test before exercise training
Secondary dynamic balance Balance will be evaluated using one-legged standing test eight week
Secondary functional mobility functional mobility will be evaluated time-up go test before exercise training
Secondary functional mobility functional mobility will be evaluated time-up go test eight week
Secondary Mcgill core endurance test Endurance of trunk muscles will be evaluated trunk flexor, trunk extensor and side plank test before exercise training
Secondary Mcgill core endurance test Endurance of trunk muscles will be evaluated trunk flexor, trunk extensor and side plank test eight week
Secondary Quality of life assessment Quality of life will be evaluated using the Cystic Fibrosis Questionnaire-Revised (CFQ-R).The Cystic Fibrosis Questionnaire-Revised (CFQ-R) is a disease-specific health-related quality of life (HRQOL) measure for children, adolescents with cystic fibrosis (CF). The questionnaire assess physical functioning, emotional functioning, social functioning, body image, eating disorders, treatment, respiratory symptoms and digestive symptoms.Score range is 0-100. Higher scores indicating higher health-related quality of life. before exercise training
Secondary Quality of life assessment Quality of life will be evaluated using the Cystic Fibrosis Questionnaire-Revised (CFQ-R).The Cystic Fibrosis Questionnaire-Revised (CFQ-R) is a disease-specific health-related quality of life (HRQOL) measure for children, adolescents with cystic fibrosis (CF). The questionnaire assess physical functioning, emotional functioning, social functioning, body image, eating disorders, treatment, respiratory symptoms and digestive symptoms.Score range is 0-100. Higher scores indicating higher health-related quality of life. eight week
Secondary Physical activity assessment Physical activity levels will be assessed by The Physical Activity Questionnaire. Score range is 1-5. Higher scores indicating higher physical activity before exercise training
Secondary Physical activity assessment Physical activity levels will be assessed by The Physical Activity Questionnaire. Score range is 1-5. Higher scores indicating higher physical activity eight week
See also
  Status Clinical Trial Phase
Completed NCT04696198 - Thoracic Mobility in Cystic Fibrosis Care N/A
Completed NCT00803205 - Study of Ataluren (PTC124™) in Cystic Fibrosis Phase 3
Terminated NCT04921332 - Bright Light Therapy for Depression Symptoms in Adults With Cystic Fibrosis (CF) and COPD N/A
Completed NCT03601637 - Safety and Pharmacokinetic Study of Lumacaftor/Ivacaftor in Participants 1 to Less Than 2 Years of Age With Cystic Fibrosis, Homozygous for F508del Phase 3
Terminated NCT02769637 - Effect of Acid Blockade on Microbiota and Inflammation in Cystic Fibrosis (CF)
Recruiting NCT06032273 - Lung Transplant READY CF 2: CARING CF Ancillary RCT N/A
Recruiting NCT06012084 - The Development and Evaluation of iCF-PWR for Healthy Siblings of Individuals With Cystic Fibrosis N/A
Recruiting NCT06030206 - Lung Transplant READY CF 2: A Multi-site RCT N/A
Recruiting NCT06088485 - The Effect of Bone Mineral Density in Patients With Adult Cystic Fibrosis
Recruiting NCT05392855 - Symptom Based Performance of Airway Clearance After Starting Highly Effective Modulators for Cystic Fibrosis (SPACE-CF) N/A
Recruiting NCT04056702 - Impact of Triple Combination CFTR Therapy on Sinus Disease.
Recruiting NCT04039087 - Sildenafil Exercise: Role of PDE5 Inhibition Phase 2/Phase 3
Completed NCT04038710 - Clinical Outcomes of Triple Combination Therapy in Severe Cystic Fibrosis Disease.
Completed NCT04058548 - Clinical Utility of the 1-minute Sit to Stand Test as a Measure of Submaximal Exercise Tolerance in Patients With Cystic Fibrosis During Acute Pulmonary Exacerbation N/A
Completed NCT03637504 - Feasibility of a Mobile Medication Plan Application in CF Patient Care N/A
Recruiting NCT03506061 - Trikafta in Cystic Fibrosis Patients Phase 2
Completed NCT03566550 - Gut Imaging for Function & Transit in Cystic Fibrosis Study 1
Recruiting NCT04828382 - Prospective Study of Pregnancy in Women With Cystic Fibrosis
Completed NCT04568980 - Assessment of Contraceptive Safety and Effectiveness in Cystic Fibrosis
Recruiting NCT04010253 - Impact of Bronchial Drainage Technique by the Medical Device Simeox® on Respiratory Function and Symptoms in Adult Patients With Cystic Fibrosis N/A